MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
LYEL Cash Flow Sankey DiagramSankey diagram visualizing LYEL cash flow for the periodMaturities of marketablesecurities$69,390K (-71.98%↓ Y/Y)Proceeds from employeestock purchase plan$522K (183.70%↑ Y/Y)Sales of property andequipment$5K Net cash provided byinvesting activities$15,616K (-80.98%↓ Y/Y)Net cash provided byfinancing activities$522K (183.70%↑ Y/Y)Canceled cashflow$53,779K Net increase(decrease) in cash, cash...-$17,784K (-157.78%↓ Y/Y)Canceled cashflow$16,138K Accrued liabilities andother current...$4,608K (135.13%↑ Y/Y)Stock-based compensationexpense$4,532K (-58.90%↓ Y/Y)Prepaid expenses, othercurrent assets and other...-$3,235K (32.55%↑ Y/Y)Depreciation andamortization expense$2,222K (-66.21%↓ Y/Y)Loss on property andequipment disposals, net-$117K (96.89%↑ Y/Y)Other non-currentliabilities$10K (104.48%↑ Y/Y)Purchases of marketablesecurities$53,523K (-67.58%↓ Y/Y)Purchases of property andequipment$256K (-38.16%↓ Y/Y)Net cash used inoperating activities-$33,922K (61.97%↑ Y/Y)Canceled cashflow$14,724K Net loss-$44,755K (52.83%↑ Y/Y)Accounts payable-$1,464K (22.33%↑ Y/Y)Non-cash lease income$1,206K (-20.45%↓ Y/Y)Net amortizationand accretion on...$822K (-71.56%↓ Y/Y)Change in fair value ofsuccess payment...-$399K (-66.25%↓ Y/Y)

Lyell Immunopharma, Inc. (LYEL)

Lyell Immunopharma, Inc. (LYEL)

Cash Flow
Quarterly Cash Flow Statement for the quarter ending in 2026-06-30
source: myfinsight.com